ANIC Agronomics Limited

TIDMPEBI

RNS Number : 7471W

Port Erin Biopharma Investments Ltd

28 April 2016

29 April 2016

Port Erin Biopharma Investments Limited

(the "Company")

Net Asset Value calculation to 31 March 2016

Jim Mellon, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2016 was 10.21 pence per share, including un-invested cash of GBP10,713. The portfolio is valued under IFRS at bid price.

Net Assets stand at GBP2.4 million including Investments of GBP2.38 million. This quarter's NAV represents a decrease of 5.37% from the previous valuation of 10.79 pence per share, which included un-invested cash of GBP24,011. No additional management fee is due to Shellbay Investments Limited."

 
                                                     Unaudited to 31 March 2016 (GBP) 
Fixed Assets 
 Investments                                                                2,375,370 
Current Assets 
 Sundry Debtors                                                                34,522 
 Uninvested cash                                                               10,713 
Current Liabilities 
 Creditors: amounts due                                                      (51,777) 
                                                     -------------------------------- 
                                                                            2,368,828 
Capital and Reserves 
 Share Capital                                                                     23 
 Share Premium                                                              1,890,142 
 Reserves                                                                     478,663 
                                                     -------------------------------- 
                                                                            2,368,828 
 
Shares in Issue                                                            23,195,558 
 
Net Asset Value per share                                                 10.21 pence 
 

Portfolio Details

 
 Investments as at 31              Value  % of Total Portfolio 
  March 2016 
-------------------------  -------------  -------------------- 
 
 Magna Biopharma Income 
  Fund                      GBP1,093,235                 46.0% 
 Regent Pacific Group         GBP600,945                 25.3% 
 Summit Corporation           GBP251,293                 10.6% 
 Other quoted holdings         GBP96,082                  4.0% 
 Other unquoted holdings      GBP333,815                 14.1% 
 
 Total                      GBP2,375,370                100.0% 
-------------------------  -------------  -------------------- 
 

For further information, please contact:

 
Port Erin Biopharma     Northland Capital      Peterhouse Capital 
 Investments Limited     Partners               Limited 
                         Limited 
The Company             Nomad and Joint        Broker 
                         Broker 
 
Denham Eke              Matthew Johnson/David  Lucy Williams 
 (+44) (0) 1624 639396   Hignell                (+44) (0) 207 469 0936 
                         (+44) (0) 203 861 
                         6625 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NAVSELESAFMSESL

(END) Dow Jones Newswires

April 29, 2016 02:00 ET (06:00 GMT)

Agronomics (LSE:ANIC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Agronomics (LSE:ANIC)
Historical Stock Chart
From Apr 2023 to Apr 2024